Martin Shkreli, the former pharmaceutical industry executive and hedge fund manager who is facing trial on accusations that he defrauded investors, is now starting a Manhattan software company that is in the midst of a $1 million debt offering, according to a regulatory filing.

Godel Systems is the company's name, and a job posting for the company notes that its founder is "an elite entrepreneur" with a "tremendous track record." A filing with the Securities and Exchange Commission, unearthed by CNBC, said Godel Systems has already raised $50,000. The issued debt is convertible to "equity securities."

Shkreli came to public attention—and scorn—in 2015 when Turing Pharmaceuticals, the second pharma company he founded, dramatically hiked the price of the life-saving drug Daraprim. The decades-old drug is used to treat a parasitic infection and is often given to AIDS patients and babies. The price increase brought attention to the skyrocketing costs of drugs, and it also opened up a host of criminal legal troubles for Shkreli.

Shkreli is to appear in a New York federal court this summer to face a variety of charges, including securities fraud and wire fraud. Shkreli, who has pleaded not guilty, allegedly defrauded investors of two former hedge funds he managed and misappropriated $11 million in assets from Retrophin, a biopharmaceutical company he once headed, according to an indictment. Separately, the SEC is suing Shkreli on accusations that he misappropriated funds from MSMB Capital Management (a fund he founded) and that he made material misrepresentations to investors about the fund's health.

Godel Systems, in which Shkreli is listed as a director and executive officer, does not have a website to explain the company. A job listing for a "Full Stack JavaScript Developer" says Godel "is a professional software company that aims to be the leading information provider of data, workflow, and communications solutions for financial, law, and scientific professionals. Godel's first vertical will target the $27bill+ financial market with additional future verticals planned in law and science. We plan to revolutionize the data aggregation and communications model for millions of users across multiple industries in new and exciting ways."